A Study to Learn About How a New Nurandociguat Tablet is Absorbed and Processed in the Body Compared to an Old Tablet and How Food Affects the Way the New Tablet is Absorbed and Processed in the Body

Clinical trial NCT07722585 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07722585
Sponsor: Bayer
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Kidney Disease

Start date: 2026-07-28
Primary completion: 2026-11-04
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.